Ardelyx inc.

Major-Pharmaceuticals

ARDX


34175 Ardenwood Boulevard
Fremont , CA 94555

Executive/
Director

Price

  • Last Close
  • $ 6.13
    $ -0.03 -0.49 %
    Aug 29, 2024
  • 52-Week High/Low
  • $9.74 - $3.29
  • YTD
  • -1.1%

  • Trading Volume
  • 62,550
  • Market Cap Full
  • $ 1.4B
  • Shares Outstanding
  • 232.1M
    Oct 26, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -30.7% -57.1% -10.9% -23.5% 56.4% -5% 0.5% -2.7% 68.1% 17.7%
Q2 22% 12.4% -59.7% -25.3% -9.6% 4% 16.6% -44.9% -29.2% -0.8%
Q3 8.2% 48.2% 9.8% 16% 71.9% 8% -82.6% 101.7% 20.4% -
Q4 4.9% 9.7% 3.1% -57% 57.7% 20.9% -16.7% 139.5% 52.7% -
J F M A M J J A S O N D
2024 40.8% 6.8% -21.7% 0.7% - - - - - - - -
2023 2.8% -1.7% 66.3% -6.9% -25.1% 1.5% 16.2% 8.1% -4.2% -3.2% 14.2% 37.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-4%-22%-54%-73%321%-14%-83%159%118%-1%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.19 0.70 0.59 -0.36 -0.42 -0.25 -0.34 -0.21 -0.13
Q2 0.42 0.83 0.54 -0.42 -0.41 -0.28 -0.45 -0.19 -0.08
Q3 0.70 0.65 0.44 -0.39 -0.37 -0.2 -0.42 -0.14 0.03
Q4 0.65 0.66 0.21 -0.45 -0.27 -0.32 -0.31 0.12 -
A 2 2.8 1.8 -1.6 -1.5 -1.1 -1.5 -0.4 -0.18

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 62.6 88.9 98.7 130.3 206.5
Jun 47.6 62.6 89.1 98.7 144.6 214.5
Sep 62.1 62.8 89.1 103.1 154.6 217.9
Dec 62.1 62.9 90.2 112.7 187.5 232.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.3 - - - -
Fixed Asset Turnover 26 3.3 1.6 1.7 0.4
Total Asset Turnover 0.3 0.1 - - -
Leverage
Debt Ratio - - 0.2 0.2 0.3
Debt – Equity Ratio - - 0.4 0.3 0.4
Interest Coverage -21.3 -38.5 -30.3 -22.8 -
Equity multiplier - - - - 0.1